Indication and Important Safety Information
PULMICORT RESPULES is developed and approved specifically for children 12 months to 8 years of age, to help prevent asthma symptoms that could lead to an attack.
PULMICORT RESPULES, an inhaled corticosteroid, is not a quick-relief medication and should NOT be used to treat an acute asthma attack. In studies, side effects included respiratory infection, runny nose, earache, and coughing. Inhaled corticosteroids may cause a reduction in growth rate. The long-term effect on final adult height is unknown. If switching to PULMICORT RESPULES from an oral (syrup or pill) corticosteroid, follow the doctor's instructions to help avoid health risks. Tell the doctor if your child is exposed to chicken pox or measles.
Talk to your doctor about PULMICORT RESPULES.